key: cord-0705961-wgo77q4o
authors: Mohammadpour, Mehdi; Yazdi, Hamidreza; Bagherifard, Abolfazl; Jabalameli, Mahmoud; Moghtadaei, Mehdi; Torkaman, Ali; Yahyazadeh, Hooman; Ghaderi, Mohammad Taher; Fanaeian, Mohammad Mahdi; Langeroudi, Moein Khaleghi; Hashemi, Peyman; Razi, Saeed; Karimpour, Amer; Lirgeshasi, Sam Bemani; Bahari, Milad
title: Evaluation of early complications, outcome, and mortality in Coronavirus Disease 2019 (COVID-19) infection in patients who underwent orthopedic surgery
date: 2022-01-18
journal: BMC Musculoskelet Disord
DOI: 10.1186/s12891-022-05010-8
sha: 8ac222089f6a4ab4d679e6a4d91906e66e703ea5
doc_id: 705961
cord_uid: wgo77q4o

BACKGROUND: A higher mortality and morbidity rate has been reported in COVID-19 patients undergoing surgery. To reduce the morbidity and mortality rate in COVID-19 patients undergoing orthopedic procedures, we aimed to increase the threshold for surgical planning. METHODS: In a prospective cohort study, COVID-19 patients who underwent elective or emergent orthopedic surgery in three orthopedic surgery centers from February 2020 to September 2020 were included. In this period, 6751 patients were scheduled for orthopedic surgery. To increase surgical threshold planning, all patients with grade 5 of the American Society of Anesthesiologists (ASA) classification and patients with COVID-19 related moderate to severe pulmonary involvement were identified as high-risk patients and were excluded. RESULTS: 35 deaths occurred during the study. The frequency of deaths was significantly higher in patients with COVID-19, 6 (9.4%) than patients without COVID-19, 29 (0. 43%). The average hospitalization stay was 12.8 ± 12.1 days. The odds ratio (OR) for death was significantly higher in patients with COVID-19 than patients without COVID-19. [OR: 8.13, Confidence interval 95% (CI95%) (5.02–11.25), P: 0.001]. Four (6.3%) COVID-19-associated complications were recorded in this series that all were respiratory failure requiring unexpected postoperative ventilation. Twenty surgical complications (31.3%) were recorded. The odds ratio for ICU admission was significantly higher in patients with COVID-19 than patients without COVID-19. [OR: 5.46, CI 95% (2.68–8.68), P: 0.001]. CONCLUSIONS: An increased threshold for orthopedic surgery is suggested for COVID-19 patients with a mortality rate of 9.3%, which is less than the mortality rate in other studies. Level of evidence III. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12891-022-05010-8.

The COVID-19 pandemic, caused by severe acute respiratory syndrome virus-2 (SARS-CoV-2), has turned into the biggest challenge of the twenty-first century [1] . This challenge is even bigger for vulnerable populations at a Open Access *Correspondence: miladbahari@ymail.com 1 Bone and Joint Reconstruction Research Center, Department of Orthopedics, School of Medicine, Iran University of Medical Sciences, Tehran, Iran Full list of author information is available at the end of the article Page 2 of 9 Mohammadpour et al. BMC Musculoskeletal Disorders (2022) 23:64 higher risk of COVID-19 morbidities and mortality [2] . Old age, obesity, comorbidities such as diabetes mellitus, chronic obstructive pulmonary disease (COPD), chronic kidney disease, severe cardiovascular diseases (e.g., heart failure and coronary artery disease), cancer, the immunocompromised state in solid organ transplant, and smoking are acknowledged as the established risk factors for severe COVID-19 infection and subsequent increased mortality [3] [4] [5] [6] .

Patients infected with COVID-19 who undergo surgery are prone to subsequent pulmonary complications because of the release of the pro-inflammatory cytokines, immunosuppressive responses to surgery, and mechanical ventilation [7] . A higher rate of mortality and pulmonary complications in COVID-19 patients undergoing surgery has been reported in several studies, which are 21.1 to 32.4% [8] [9] [10] [11] .

Considering the higher risk of mortality in COVID-19 patients undergoing surgery, the risks and benefits of surgery in these patients should be thoroughly assessed. For this purpose, surgery-specific risk evaluation of COVID-19 morbidity and mortality is of significant value [8] .

To reduce the mortality and morbidity rate in patients undergoing orthopedic procedures, we aimed to increase the threshold for orthopedic surgical planning. We hypothesized that this modification might reduce the rate of mortality.

The ethics committee approved this multi-center prospective study of our institute. Participants signed a written informed consent to use their medical data for publication. Between February 20 and September 20, 2020, 6751 patients who underwent orthopedic surgery were included in the study. Patients were then divided into two groups based on the presence or absence of the COVID-19 infection virus. Group 1 was the patients who underwent surgery and were infected with the COVID-19 infection virus. Group 2 patients underwent orthopedic surgery and were not infected with the COVID-19 infection virus. Data were collected using a checklist and from patients' medical records. Patients infected with COVID-19 who underwent elective or emergency surgery in three hospitals were prospectively evaluated for eligibility criteria. The inclusion criteria were; the age of > 18 years, non-pregnant women, a definite diagnosis of COVID-19 by Real-Time RNA specific Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) or computed tomography (CT) scan imaging (pneumonia), and oxygen saturation of 94% or less [12] . diagnosis of COVID-19 by a senior physician specialized in infectious diseases and a minimum postoperative follow-up of 30 days. The diagnosis was based on clinical presentations suggestive of COVID-19 infection [13] . The findings of CT were described as bilateral lung opacities and lobular and sub-segmental areas of consolidation [14] .

We opted for an increased surgical threshold during the COVID-19 pandemic so that surgical procedure for high-risk patients was postponed as much as possible. In this respect, patients with grade 5 of the ASA classification were excluded in both groups from the beginning of the study (n = 7), patients with moderate to severe COVID-19 pulmonary involvement (lung involvement equal or more than 50%) [14] (n = 6), were identified and excluded (Appendix 1). two patients were also excluded due to loss of follow-up (n = 2) (Fig. 1) .

Finally, 64 patients with COVID-19 and 6682 without COVID-19 who underwent orthopedic surgery during the study period were enrolled. For emergent cases with a clinical diagnosis of COVID-19, a chest x-ray (CXR), chest computed tomography (CT) scan, and laboratory tests including complete blood count (CBC), Erythrocyte Sedimentation Rate (ESR), and C-reactive protein (CRP) were done.

RT-PCR (Reverse Transcription Polymerase Chain Reaction) test was performed on 44 patients. PCR test was positive for 20 patients and harmful for 24 patients. In contrast, no PCR was performed for 20 patients. We confirmed the clinical diagnosis of COVID-19 with RT-PCR in 20 cases. As mentioned in our study, 20 patients were diagnosed when our center was not equipped with this laboratory test for PCR diagnostic test of this disease. PCR test was only available about 4 months after the start of the COVID-19 pandemic that was based on the detection of viral Ribonucleic acid (RNA) in samples obtained from nasal swabs or bronchoalveolar lavage.. At the last follow-up, antibody tests were performed on all cases. The result of the antibody test was positive for all patients.

Patient demographics, clinical, laboratory, surgical, and hospitalization data were recorded. The primary outcome of interest was mortality within 30 days after the surgery. The secondary outcome of interest was complications within 30 days past the surgery. Two groups were compared in terms of outcomes.

The mean and standard deviation (SD) were conducted for the descriptive analysis of continuous variables and qualitative data; the descriptive analysis was performed using frequencies. We used Kolmogorov-Smirnov and Shapiro-Wilk normality tests, P-P plot, and histogram to test the normality of our study population. For the continuous variables, a t-test was employed to analyze the difference; however, the Mann-Whitney U test was used in non-parametric conditions. A chi-squared test (χ2 test) was conducted for the classified variables. A two-tailed P value of < 0.05 was considered statistically significant. Multivariate logistic regression analysis was used to control confounding variables. Variables with P < 0.10 in the univariate analysis were entered into a multivariate logistic regression analysis using the backward selection method. The odds ratio adjusted was used to report the results. The statistical analyses were performed using the SPSS 20.0 (SPSS Inc) software. were observed for the demographic characteristics of the patients in the two groups. (p > 0.05) Table 1 .

Elective patients diagnosed with COVID-19 developed COVID-19 after surgery and even after discharge and were not infected before surgery. The majority of the patients (34.3%) were asymptomatic; then, fever was the main clinical symptom of COVID-19 that was present in 30 (46.8%) patients alone or combined with other clinical symptoms ( Table 2) . As mentioned, several patients were asymptomatic. Because, before surgery, all patients underwent screening with a preliminary laboratory examination and lung CT scan.

Overall, the surgery was emergent in most patients 89.1% in patients with COVID-19 and 88.3% in patients without . This difference was not statistically significant in the two groups. (p:0.69) ASA grade 2 was the most frequent grade of anesthesia, 77.6%. The lower extremity was the most frequent site of surgery 41.8%. No statistically significant differences were observed for Priority, Involve limb, Type of surgery, ASA grade, and Type of anesthesia in the two groups. (p > 0.05) ( Table 3) . 

In this prospective cohort study, we evaluated the mortality rate and complications in patients with and without COVID-19 who underwent orthopedic procedures with an increased threshold for surgical planning. In total, 20 postoperative complications occurred in this series. The overall mortality rate was 0.52% (35 out of 6746). The mortality rates in patients with and without COVID-19 were 9.4% and 0.43, respectively. The frequency of admission to ICU was significantly higher in patients with COVID-19. Four of these deaths (6.2%) were associated with COVID-19 and due to respiratory failure. All patients with COVID-19 associated deaths were over 55 years and had comorbid disorders such as diabetes mellitus (n = 2) and diabetes mellitus with cardiopulmonary (n = 2). The influence of COVID-19 on postoperative mortality of patients undergoing orthopedic surgery has been investigated in a few numbers of other studies. Our study showed that the mortality rate in patients with COVID-19 after orthopedic surgery was significantly higher than patients without COVID-19, which was consistent with the results of previous studies in this field [15, 16] . Nepogodiev 4 (56 of 68) . In addition, our study's duration was longer than the Clement study (7 months vs. 1.6 months), and more patients were evaluated (6746 vs. 1659).

Sobti et al. compared the mortality rate in patients with femoral neck fracture with or without COVID-19. From a total of 94 patients who were operated on for femoral neck fracture, nine deaths were recorded that three of them were COVID-19 positive, five were COVID-19 negative, and the other one was not tested. According to their conclusion, the mortality rate in patients undergoing surgery for femoral neck fracture was not significantly different compared to the cohort performed before COVID-19 lockdown [17] . Considering the high mortality rate of a femoral neck fracture, particularly in the geriatric population [18] .

Several other studies have also studied the mortality and morbidity rate in COVID-19 patients undergoing different surgical procedures. Wang et al., in a metaanalysis study of 269 patients from 47 studies, evaluated the factors affecting the mortality of COVID-19 patients undergoing surgery. The mean age of the patients was 50.9 years. The overall rate of mortality was 6%. All deceased patients had complications associated with either surgery or COVID-19. Patients with severe respiratory complications at presentation had higher postoperative mortality [19] . These results further highlight the importance of a higher threshold for surgical procedures during the COVID-19 pandemic.

Abate et al. assessed the postoperative mortality rate in COVID-19 undergoing surgery in a meta-analysis of 33 studies with 2947 participants. According to this study, the postoperative mortality rate among COVID-19 patients was 20%. The postoperative ICU admission rate was 15% [11] . In the present study, the postoperative mortality and ICU admission rates were 9.3 and 46.9%.

Besides the increased mortality and morbidity rate in COVID-19 patients undergoing orthopedic surgeries, SARS-CoV-2 infection has other adverse impacts on the management of patients, such as in the diagnosis of postoperative infection. Since COVID-19 disease could be associated with increased ESR and CRP levels [20, 21] , identification of surgical site infection in patients with COVID-19 could be challenging. In addition, the hospitalization stay of diabetic patients is a matter of concern. Based on our study, diabetic patients are one of the most vulnerable groups to COVID-19. A more extended hospitalization stay could increase the possibility of COVID-19 infection. At the same time, the patients require intensive care in the hospital, and a shorter hospital stay increases the probability of diabetic foot sepsis. Our study evaluated a large sample size of orthopedic surgeries, and multivariate logistic regression analysis was used to control confounding variables. The prospective study design was another strength of our study compared to other studies. COVID-19 mortality rates have also been reported based on underlying diseases and socioeconomic [6, [22] [23] [24] . According to our research so far, the study in Iran has not evaluated the outcomes of COVID-19 in orthopedic surgeries. Our study was conducted in a multi-center for the first time in Iran. The present study was not without limitations. The main end of this study was the small number of COVID-19 patients, which did not allow statistical evaluation of the risk factors associated with the morbidity and mortality of COVID-19 patients undergoing orthopedic surgeries. Due to the unknown nature of this disease in the early pandemic, based on the literature and opinions of orthopedic specialists, only the factors that could worsen patients in orthopedic surgery were recorded and evaluated. Therefore, a few items related to orthopedic surgery were assessed. Therefore, future studies with larger patients' numbers and broader factors associated with orthopedic surgery may be required for a detailed evaluation of the risk factors of morbidity and mortality in these patients. PCR test was not available from the beginning of this study, and we made the diagnosis based on laboratory findings and lung CT scan. The strength of this study was the multicenter study design and the high sample size of this study.

According to our observation, Covid-19 increased the chances of mortality and ICU admission, even in patients with a higher threshold for surgery who underwent orthopedic surgery than those without Covid-19.

Challenges for management of the COVID-19 epidemic in Iran

Identification of Vulnerable Populations and Areas at Higher Risk of COVID-19 Related Mortality in the US. medRxiv

COVID-19): evidence used to update the list of underlying medical conditions that increase a person's risk of severe illness from COVID-19

COVID-19): who is at increased risk for severe illness? -people of any age with underlying medical conditions

Predictors for the severe coronavirus disease 2019 (COVID-19) infection in patients with underlying liver disease: a retrospective analytical study in Iran

Should all patients with hypertension be worried about developing severe coronavirus disease 2019 (COVID-19)?

We asked the experts: Covid-19 outbreak: is there still a place for scheduled surgery?"reflection from pathophysiological data

Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study

Perioperative SARS-CoV-2 infections increase mortality, pulmonary complications, and thromboembolic events: a Dutch, multicenter, matched-cohort clinical study

IMPACT-restart: the influence of COVID-19 on postoperative mortality and risk factors associated with SARS-CoV-2 infection after orthopaedic and trauma surgery

Postoperative mortality among surgical patients with COVID-19: a systematic review and meta-analysis

Effect of arbidol on COVID-19: a randomized controlled trial

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

Chest CT findings in coronavirus disease-19 (COVID-19): relationship to duration of infection

Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study

Perioperative morbidity and mortality of patients with COVID-19 who undergo urgent and emergent surgical procedures

Outcome of trauma and orthopaedic surgery at a UK District general hospital during the Covid-19 pandemic

Operative mortality after arthroplasty for femoral neck fracture and hospital volume

Factors affecting the mortality of patients with COVID-19 undergoing surgery and the safety of medical staff: a systematic review and meta-analysis

Biomarkers associated with COVID-19 disease progression

Association of inflammatory markers with the severity of COVID-19: a meta-analysis

Predictors for the severe coronavirus disease 2019 (COVID-19) infection in patients with underlying liver disease: a retrospective analytical study in Iran

Socioeconomic disparities in subway use and COVID-19 outcomes in new York City

Association of socioeconomic characteristics with disparities in COVID-19 outcomes in Japan

The online version contains supplementary material available at https:// doi. org/ 10. 1186/ s12891-022-05010-8.

Hereby, the authors would like to express gratitude to the Vice Chancellor for Iran University of Medical Sciences research.

Datasets of the current study are available by the corresponding authors on reasonable request.

MM, HY, AB, MJ, MMogh, AT, HY and MB designed the study. MTG, MMF and MKL performed the formal analysis and data investigation. MM, AB and MB wrote the original draft. PH, SR, AK and SBL reviewed and edited the article. All authors read and approved the final manuscript. Every Author agreed both to be personally accountable for the author's own contributions and to ensure that questions related to the accuracy or integrity of any part of the work.

Not applicable.

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request. 

Not applicable.

The authors have no conflicts of interest to declare for this study.